GSK gives up on rare diseases as gene therapy gets two customers

LONDON, July 26 (Reuters) – GlaxoSmithKline isswimming against the tide by getting out of treatments for rarediseases at a time when rivals like Sanofi and Shiresee the field as a rich seam for profits.
The post GSK gives up on rare diseases as gene therapy gets two customers appeared first on RocketNews | Top News Stories From Around the Globe.